Palvella Therapeutics (PVLA) Free Cash Flow (2013 - 2026)
Palvella Therapeutics (PVLA) reported Free Cash Flow of -$10.9 million for Q1 2026, down 61.05% year-over-year from -$28.0 million in Q1 2025, and down 121.54% on a QoQ basis from -$4.9 million in Q4 2025.
Palvella Therapeutics (PVLA) has 14 years of Free Cash Flow data on file, last reported at -$10.9 million in Q1 2026.
- Quarterly Free Cash Flow fell 61.05% year-over-year to -$10.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$29.1 million (down 76.49% YoY) and the FY2025 annual result came in at -$25.0 million, down 130.63% from the prior year.
- Free Cash Flow retreated to -$10.9 million in Q1 2026 per PVLA's latest filing, from -$4.9 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $20.6 million in Q4 2023 and bottomed at -$22.9 million in Q1 2022.
- The 5-year median for Free Cash Flow is -$7.9 million (2025), against an average of -$7.1 million.
- The widest annual swing landed in 2023, when Free Cash Flow surged 247.97%; it then tumbled 514.16% in 2025.
- Tracing PVLA's Free Cash Flow over 5 years: stood at -$13.9 million in 2022, then surged by 247.97% to $20.6 million in 2023, then slumped by 126.14% to -$5.4 million in 2024, then gained by 8.77% to -$4.9 million in 2025, then tumbled by 121.54% to -$10.9 million in 2026.
- Per Business Quant, the three latest PVLA Free Cash Flow figures stand at -$10.9 million (Q1 2026), -$4.9 million (Q4 2025), and -$7.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | -10.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.90 Mn |
| Mar 31, 2026 | -10.90 Mn |
| Dec 31, 2025 | -4.92 Mn |
| Dec 31, 2025 | -4.92 Mn |
| Sep 30, 2025 | -7.88 Mn |
| Sep 30, 2025 | -7.88 Mn |
| Jun 30, 2025 | -5.43 Mn |
| Jun 30, 2025 | -5.43 Mn |
| Mar 31, 2025 | -6.77 Mn |
| Mar 31, 2025 | -6.77 Mn |
| Dec 31, 2024 | -5.39 Mn |
| Dec 31, 2024 | -5.39 Mn |
| Sep 30, 2024 | -2.74 Mn |
| Sep 30, 2024 | -2.74 Mn |
| Jun 30, 2024 | -1.60 Mn |
| Jun 30, 2024 | -1.60 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | 20.63 Mn |
| Dec 31, 2023 | 20.63 Mn |
| Sep 30, 2023 | -9.83 Mn |
| Sep 30, 2023 | -9.83 Mn |
| Jun 30, 2023 | -13.46 Mn |
| Jun 30, 2023 | -13.46 Mn |
| Mar 31, 2023 | -11.04 Mn |
| Mar 31, 2023 | -11.04 Mn |
| Dec 31, 2022 | -13.94 Mn |
| Dec 31, 2022 | -13.94 Mn |
| Sep 30, 2022 | -8.79 Mn |
| Sep 30, 2022 | -8.79 Mn |
| Jun 30, 2022 | -15.30 Mn |
| Jun 30, 2022 | -15.30 Mn |
| Mar 31, 2022 | -22.94 Mn |
| Mar 31, 2022 | -22.94 Mn |
| Dec 31, 2021 | -11.89 Mn |
| Dec 31, 2021 | -11.89 Mn |
| Sep 30, 2021 | -14.23 Mn |
| Sep 30, 2021 | -14.23 Mn |
| Jun 30, 2021 | 29.68 Mn |
| Jun 30, 2021 | 29.68 Mn |
| Mar 31, 2021 | -12.17 Mn |
| Mar 31, 2021 | -12.17 Mn |
| Dec 31, 2020 | -14.00 Mn |
| Dec 31, 2020 | -14.00 Mn |
| Sep 30, 2020 | -6.73 Mn |
| Sep 30, 2020 | -6.73 Mn |
| Jun 30, 2020 | -10.84 Mn |
| Jun 30, 2020 | -10.84 Mn |
| Mar 31, 2020 | -17.06 Mn |
| Mar 31, 2020 | -17.06 Mn |
| Dec 31, 2019 | -15.15 Mn |
| Dec 31, 2019 | -15.15 Mn |
| Sep 30, 2019 | -12.88 Mn |
| Sep 30, 2019 | -12.88 Mn |
| Jun 30, 2019 | -11.67 Mn |
| Jun 30, 2019 | -11.67 Mn |
| Mar 31, 2019 | -15.23 Mn |
| Mar 31, 2019 | -15.23 Mn |
| Dec 31, 2018 | -9.62 Mn |
| Dec 31, 2018 | -9.62 Mn |
| Sep 30, 2018 | -14.68 Mn |
| Sep 30, 2018 | -14.68 Mn |
| Jun 30, 2018 | -9.38 Mn |
| Jun 30, 2018 | -9.38 Mn |
| Mar 31, 2018 | 30.93 Mn |
| Mar 31, 2018 | 30.93 Mn |
| Dec 31, 2017 | -5.51 Mn |
| Dec 31, 2017 | -5.51 Mn |
| Sep 30, 2017 | 34.91 Mn |
| Sep 30, 2017 | 34.91 Mn |
| Jun 30, 2017 | -7.19 Mn |
| Jun 30, 2017 | -7.19 Mn |
| Mar 31, 2017 | 25.59 Mn |
| Mar 31, 2017 | 25.59 Mn |
| Dec 31, 2016 | -6.97 Mn |
| Dec 31, 2016 | -6.97 Mn |
| Sep 30, 2016 | -3.77 Mn |
| Sep 30, 2016 | -3.77 Mn |
| Jun 30, 2016 | -6.17 Mn |
| Jun 30, 2016 | -6.17 Mn |
| Mar 31, 2016 | 1.96 Mn |
| Mar 31, 2016 | 1.96 Mn |
| Dec 31, 2015 | -2.84 Mn |
| Dec 31, 2015 | -2.84 Mn |
| Sep 30, 2015 | -3.73 Mn |
| Sep 30, 2015 | -3.73 Mn |
| Jun 30, 2015 | -3.12 Mn |
| Jun 30, 2015 | -3.12 Mn |
| Mar 31, 2015 | -3.63 Mn |
| Mar 31, 2015 | -3.63 Mn |
| Sep 30, 2014 | -13,918.00 |
| Sep 30, 2014 | -13,918.00 |
| Jun 30, 2014 | -3.41 Mn |
| Jun 30, 2014 | -3.41 Mn |
| Mar 31, 2014 | -420,245.00 |
| Mar 31, 2014 | -420,245.00 |
| Dec 31, 2013 | -948.00 |
| Dec 31, 2013 | -948.00 |
| Sep 30, 2013 | -4,512.00 |
| Sep 30, 2013 | -4,512.00 |
| Jun 30, 2013 | -274.00 |
| Jun 30, 2013 | -274.00 |